Depression Clinical Trials in Miami, FL

Depression Clinical Trials in Miami, FL

View the best 10 depression medical studies in Miami, Florida. Access promising new therapies by applying to a Miami-based Depression clinical trial.

Trials in Miami, Florida

Here are the top 10 medical studies for depression in Miami, Florida

Image of Advanced Research Center /ID# 227073 in Anaheim, United States.

Placebo +1 More

Pharmacotherapy

Recruiting1 awardPhase 3
This trial is testing the safety and effectiveness of Cariprazine for treating depressive episodes in children and teenagers with bipolar I disorder. The goal is to find out if Cariprazine can help young people with this condition. Cariprazine is an atypical antipsychotic recently approved for the treatment of depressive episodes in adults with bipolar I disorder.
Image of University of Miami in Coral Gables, United States.

Modifying Exploration

Recruiting1 award4 criteria
This trial explores how our environment, thoughts, emotions, and brain activity are connected, using smartphones to collect data.
Image of University of Miami in Miami, United States.

Cognitive-Behavioral Therapy for Adherence and Depression (CBT-AD)

Behavioral Intervention

Recruiting1 award
This trial will test if a psychological treatment for depression can also help improve the gut microbiome, immune system, and brain functioning in people living with HIV.
Image of Clinical Site in Anaheim, United States.

Lumateperone

Behavioural Intervention

Recruiting1 awardPhase 3
"This trial is studying the effectiveness of a new treatment for children with bipolar disorder who are also experiencing major depressive episodes. The study is being conducted at multiple locations and will involve random assignment of participants to receive
Image of Neumora Investigative Site in Orlando, United States.

NMRA-335140

Verified
Recruiting2 awardsPhase 3
This trial is testing a new medication called NMRA-335140 to see if it helps people with major depressive disorder. It includes participants who have no safety concerns. The medication aims to improve mood by affecting brain chemicals.
Image of Chicago Research Center in Chicago, United States.

Aticaprant

Recruiting1 awardPhase 3
This trial aims to see if aticaprant is effective in preventing the return of depression symptoms when added to antidepressant therapy in individuals with major depressive disorder who have already responded well to aticaprant treatment
Image of Sante Cannabis in Montréal, Canada.

IGC-AD1

Cannabinoid

Recruiting0 awardsPhase 2
This trial tests a natural THC-based medicine called IGC-AD1, given in small doses regularly. It targets people aged 60 and above with Alzheimer's-related dementia who have been experiencing agitation. The THC in the medicine helps reduce agitation by interacting with brain signals. The most recent trial reported significant improvement in agitation using nabilone.
Image of Synexus – Atlanta in Sandy Springs, United States.

NMRA-335140

Behavioural Intervention

Verified
Recruiting1 awardPhase 3
This trial is testing a new medication called NMRA-335140 to see if it can help people with severe depression. The study involves participants with Major Depressive Disorder and aims to find out if the medication can improve their mood by altering brain chemicals.
Image of Vilma Gabbay, MD, MS in Bronx, United States.

PLWH

Recruiting1 award
This trial is studying how using cannabis and having depression together affect young people living with HIV. Researchers believe that these conditions combined might make it harder for them to feel pleasure and could increase their sensitivity to pain. The goal is to see if these effects lead to worse health outcomes over time.
Image of Clinical Site in Pico Rivera, United States.

Lumateperone 42 mg

Recruiting1 awardPhase 3
This trial is testing lumateperone, a medication that may help people with depression who haven't improved with other treatments. The study includes patients diagnosed with Major Depressive Disorder who haven't responded well to their current antidepressants. Lumateperone works by balancing brain chemicals that affect mood, potentially improving depressive symptoms.

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.